FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds of general formula (I) wherein R means phenyl which can have one or more substitutes - halogen; or its pharmaceutically acceptable salt.
EFFECT: compounds may be used in CRTH2-mediated diseases, such as asthma, allergic rhinitis, etc.
16 cl, 13 dwg, 13 tbl, 5 ex
Authors
Dates
2012-08-20—Published
2007-07-20—Filed